Learn More
Description
p27 (Kip1) is a cyclin-dependent kinase inhibitor (cdkI) that associates with cyclin/cdk complexes to inhibit their catalytic activity. p27 was first identified as a result of its role in TGF-β-induced G1 phase arrest and cell-cell contact. In vitro, p27 binds tightly to cyclin D-Cdk4, cyclin E-Cdk2, and cyclin A-Cdk2 complexes to inhibit their activity. In non-dividing cells, the level of p27 is elevated and its activity gradually decreases as cells reach S phase. Mitogenic stimulation causes the cyclin D-CDK complex to bind and sequester p27. An increase in Cdk2 activity during G1 causes the degradation of p27. Phosphorylation of p27 is necessary for its degradation and is mediated by the SCF complex (Skp1,2/Cdc53 (cullins))/F-box proteins. SCF complexes are involved in targeting phosphorylated proteins for ubiquitin-dependent proteolysis. The antibodies recognize mouse p27. A peptide coupled to KLH and corresponding to amino acids 184-197 at the C-terminus of mouse p27 was used as immunogen.
Western Blotting
Specifications
Specifications
| Antigen | p27 |
| Applications | Immunoprecipitation, Western Blot |
| Classification | Polyclonal |
| Clone | POLYCLONAL |
| Conjugate | Unconjugated |
| Host Species | Rabbit |
| Immunogen | Mouse p27 aa. 184-197 peptide |
| Quantity | 0.1 mL |
| Regulatory Status | RUO |
| Research Discipline | Cell Biology |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.